Uruguay

Montevideo, October 6, 2026. Uruguayan media reported as early as Monday, October 5, the awarding of the 2026 Nobel Prize in Medicine to American Karl Deisseroth and Germans Peter Hegemann and Georg Nagel. Subrayado headlines a prize awarded "to an American and two Germans for advances in optogenetics". El Observador specifies that the Nobel Assembly of the Karolinska Institute distinguished them "for their discoveries on light-activated ion channels and optogenetics".

The Uruguayan account emphasizes the use of the technique. Subrayado presents it as a discipline that allows us to understand how certain cells contribute to learning, fear, addiction, and movement. The two media outlets quote the Nobel Committee: thanks to optogenetics, researchers have been able to "reveal the neural circuits that control specific memories, feelings, and behaviors" related to neurological and psychiatric disorders. They also repeat the committee's phrase that this method "has radically transformed our understanding of the brain".

The medical scope is posed in the conditional. Subrayado writes that these works "could one day lead to treatments" for neurological and sensory disorders, such as Parkinson's disease and epilepsy. El Observador adds, under a subheading on medical applications, that researchers are already using the method in clinical medicine to try to restore the vision of visually impaired people. Neither of the two articles provides a timeline for these treatments.

The two articles also describe the prize. Subrayado indicates that the winners will receive a diploma, a gold medal, and a check for $1.2 million from the hands of King Charles XVI Gustave, during a ceremony in Stockholm on December 10, the anniversary of Alfred Nobel's death in 1896. The subject is treated as an international science dispatch, without a national angle or reaction from Uruguayan researchers in the provided texts.

La diaria has chosen a humorous tone. Its satirical column announces that Deisseroth, Hegemann, and Nagel are receiving the prize "for discoveries that will be disputed on X in five years". It has a fictional spokesperson say that, despite the controversy on social networks, the contribution of these researchers to the understanding of the brain "will not be lost". The text targets the online debate, not the work itself.